Pharmacovigilance Outsourcing Market Size to Reach USD 18.88 Billion by 2031 Amid Rising Drug Safety Monitoring Demand

Introduction

According to Mordor Intelligence, the pharmacovigilance outsourcing market size is estimated at USD 9.15 billion in 2026 and is projected to reach USD 18.88 billion by 2031, registering a CAGR of 15.58% during the forecast period. The growing complexity of global regulatory frameworks and rising drug development activities are contributing to increasing demand for outsourced pharmacovigilance services.

Pharmaceutical companies are increasingly relying on external service providers to manage case processing, safety data handling, literature monitoring, and risk management activities. Outsourcing allows companies to reduce operational burden while focusing internal teams on research and product development activities. The pharmacovigilance outsourcing industry is also benefiting from the increasing use of digital reporting standards and data-driven safety monitoring systems.

Report Overview: https://www.mordorintelligence.com/industry-reports/pharmacovigilance-outsourcing-market?utm_source=openpr

Pharmacovigilance Outsourcing Market Trends

Increasing Demand for Drug Safety Monitoring Services

One of the major pharmacovigilance outsourcing market trends is the growing demand for drug safety monitoring throughout the product lifecycle. Pharmaceutical companies are handling larger volumes of clinical trial data and post-marketing safety reports, increasing the need for external pharmacovigilance support.

Growing Adoption of Technology-Based Safety Platforms

Another important pharmacovigilance outsourcing market trend is the increasing use of digital safety management platforms and automated reporting systems. Outsourcing providers are investing in electronic reporting formats, integrated safety databases, and artificial intelligence-supported workflows to improve operational efficiency.

Expansion of End-to-End Outsourcing Services

The pharmacovigilance outsourcing industry is also seeing increased demand for end-to-end service models. Pharmaceutical companies are seeking providers capable of handling both pre-marketing and post-marketing pharmacovigilance functions under a single operational framework.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/pharmacovigilance-outsourcing-market?utm_source=openpr

Pharmacovigilance Outsourcing Market Segmentation

By Service

Pre-marketing Services

Clinical Pharmacovigilance Services

Case Processing Services

Signal Detection and Risk Management Services

Safety Data Management Services

Medical Review Services

Post-marketing Services

Knowledge Process Outsourcing Services

IT Solutions and Platforms

Literature Surveillance and Reporting Services

Aggregate Reporting and PSUR/DSUR Preparation

By Therapeutic Area

Neurology

Cardiology

Oncology

Immunology

Respiratory

Orthopedic

Others

By Provider

Contract Research Organizations

Business Process Outsourcing Providers

Specialized Pharmacovigilance Technology Vendors

Hybrid Service Providers

By End User

Pharmaceutical Companies

Biopharmaceutical Companies

Medical Device Companies

Generic Drug Manufacturers

By Geography

North America

Europe

Asia-Pacific

Middle East and Africa

South America

Explore Our Full Library of Healthcare Research:
https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Competitive Landscape in the Pharmacovigilance Outsourcing Industry

The pharmacovigilance outsourcing industry includes global consulting firms, contract research organizations, and specialized safety monitoring service providers. Companies are focusing on expanding technology capabilities, global delivery networks, and integrated pharmacovigilance services to strengthen their market position.

Key Players

Qinecsa Solutions

IQVIA Inc.

ICON Plc

Oracle Corporation

Explore more insights on pharmacovigilance outsourcing competitive landscape: https://www.mordorintelligence.com/industry-reports/pharmacovigilance-outsourcing-market/companies?utm_source=openpr

Conclusion

The pharmacovigilance outsourcing market is expected to maintain strong growth as pharmaceutical companies continue increasing focus on patient safety, regulatory compliance, and efficient adverse event management. The growing complexity of global drug development and post-marketing monitoring activities is supporting long-term demand for outsourced pharmacovigilance services.

Outsourcing providers are expanding digital capabilities and integrated safety management systems to help pharmaceutical companies manage increasing reporting volumes and evolving compliance requirements. The adoption of automated workflows and electronic reporting standards is also supporting operational efficiency across the pharmacovigilance ecosystem.

For more insights on the pharmacovigilance outsourcing, please visit the Mordor Intelligence page: https://www.mordorintelligence.com/industry-reports/pharmacovigilance-outsourcing-market?utm_source=openpr

Industry Related Reports

AI Enabled Pharma Supply Chain Market:

The AI enabled pharma supply chain market is witnessing rapid growth due to increasing adoption of AI-driven logistics, demand forecasting, and inventory management solutions across pharmaceutical operations. Rising focus on supply chain efficiency, real-time analytics, and automation is further supporting market expansion globally.

Get more insights: https://www.mordorintelligence.com/industry-reports/ai-enabled-pharma-supply-chain-market?utm_source=openpr

AI in Molecule Design Market size:

The AI in molecule design market is projected to reach USD 6.37 billion by 2031, growing at a CAGR of 25.52%. Increasing integration of artificial intelligence in drug discovery workflows, rising pharmaceutical R&D investments, and growing need for faster molecule identification are driving strong market growth worldwide.

Get more insights: https://www.mordorintelligence.com/industry-reports/ai-in-molecule-design-market?utm_source=openpr

Computational Drug Discovery Market share:

The computational drug discovery market is expected to reach USD 6.47 billion by 2031, registering a CAGR of 15.49% during 2026-2031. Growing use of advanced computing technologies, increasing demand to reduce drug development timelines, and rising adoption of predictive analytics in pharmaceutical research are fueling market expansion globally.

Get more insights: https://www.mordorintelligence.com/industry-reports/computational-drug-discovery-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com

https://www.mordorintelligence.com/

This release was published on openPR.